RNS key points25 Nov 2022 07:04
· Morocco - In June 2022, Quadrise signed a new Material Transfer & Cooperation Agreement with the client. The initial industrial demonstration test is now scheduled to be completed next month. Upon success, the parties will enter discussions for potential commercial supply, with a view to signing a fuel supply agreement in the first quarter of calendar year 2023.
· MSC - In July 2022, Quadrise signed a Framework Agreement with MSC Shipmanagement ("MSC") to carry out trials of bioMSAR™ and MSAR® with a view to the commercial supply of one or both fuels to MSC's global fleet. Proof-of-concept tests are planned for H1 2023, following which MSC will run Letter of No Objection trials starting with bioMSAR™. Discussions are now underway with third parties regarding the production of the fuel for the trials. With positive trial progression, Quadrise, MSC, and other key stakeholders expect to commence discussions for commercial supply to MSC's fleet in H2 2023.
· Utah - In April 2022, Quadrise entered into a Commercial Development Agreement with Valkor Technologies LLC to commercialise both MSAR® and bioMSAR™ at its projects in Utah. The Company is targeting a commercial agreement by the end of January for the licensed supply of a Manufacturing Unit to provide fuel for MSAR® and bioMSAR™ trials as a precursor to commercial supply during 2023.
· Americas - Quadrise and its local agents are advancing discussions with candidate sites in Panama and Honduras to trial MSAR® and bioMSAR™ at power plants in H1 2023 as a precursor to potential commercial supply agreements later in the year. Joint discussions are also underway with a large refinery in the Caribbean with an interest in potential MSAR® supply and the Company continues its efforts to progress activities in Mexico.
· bioMSAR™, bioMSAR Zero & RDI -Testing of glycerine-based bioMSAR™ in relation to the MSC project has been successfully completed by Wärtsilä and affiliates at test facilities in Italy. Final test reports are expected before the end of 2022. Aquafuel diesel engine testing on bioMSAR™ and other fuel and biofuel formulations to support the new Quadrise Blend-on-Board solution is also scheduled to be completed before the end of the year.
In September 2022, Quadrise signed a Joint Development Agreement with Vertoro to investigate the use of their crude sugar oils as an alternative biofuel feedstock for bioMSAR™. RDI work continues on our bioMSAR™ Zero solution for 2030 at our QRF laboratories.